Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 63.60
+1.20 (1.92%)
At close: Dec 5, 2025
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 37.85 billion as of December 5, 2025. Its market cap has increased by 27.31% in one year.
Market Cap
37.85B
Enterprise Value
34.69B
Revenue
3.85B
Ranking
n/a
PE Ratio
40.41
Stock Price
63.60
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 37.85B, an increase of 3.51%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 37.85B | 43.76% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 409.56B |
| WuXi AppTec | 269.53B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.27B |
| Shanghai United Imaging Healthcare | 107.10B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |